Please login to the form below

Not currently logged in
Email:
Password:

Executive vice president of Biogen leaves

Tony Kingsley departs the firm

Biogen's executive vice president of global commercial operations has left the company and a search has been initiated for his replacement.

During the interim period, his responsibilities will be assumed by John Cox who is executive VP of pharmaceutical operations and technology.

George Scangos, CEO at Biogen, said: “Tony has made significant contributions to Biogen. He led the successful introduction of five important new products and helped serve patients around the world with our life-transforming therapies. All of us wish Tony the best in his future endeavours.”

Kingsley joined Biogen in 2010 as senior VP and during his tenure Biogen introduced five new therapies including successfully launching Tecfidera (dimethyl fumarate) – the most prescribed oral treatment for multiple sclerosis.

Scangos added: “We are pleased that John will lead our commercial operations on an interim basis. His 12 years at Biogen and in-depth knowledge our pharmaceutical and commercial operations give us great confidence that we will continue to execute on the commercial opportunities at-hand as we search for a permanent leader.”

23rd October 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics